GLP-1 RA
- Generic Name
- GLP-1 RA
Real-world Evaluation of GLP-1 Receptor Agonists (GLP-1RA) on Efficacy and Persistence, Adherence and Therapeutic Inertia Among Type 2 Diabetes Adults With Obesity
Completed
- Conditions
- Type 2 DiabetesObesity
- Interventions
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- Ana Palanca
- Target Recruit Count
- 26944
- Registration Number
- NCT05535322
- Locations
- 🇪🇸
INCLIVA, Valencia, Spain
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
- Conditions
- Cardiovascular EventsType2 DiabetesRenal Disease
- Interventions
- First Posted Date
- 2022-02-02
- Last Posted Date
- 2022-02-18
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 781430
- Registration Number
- NCT05220917
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Recruiting
- Conditions
- Type 2 Diabetes MellitusCardiovascular Diseases
- First Posted Date
- 2021-10-11
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Kaiser Permanente
- Target Recruit Count
- 270000
- Registration Number
- NCT05073692
- Locations
- 🇺🇸
Romain S. Neugebauer, Oakland, California, United States
🇺🇸Kaiser Permanente Southern California, Pasadena, California, United States
🇺🇸Kaiser Permanente Hawaii, Honolulu, Hawaii, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath